Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / APLS - Align upgraded at Stephens Novan surges on Cantor's bullish call - in today's analyst action


APLS - Align upgraded at Stephens Novan surges on Cantor's bullish call - in today's analyst action

P_Wei/E+ via Getty Images Clear aligners manufacturers sized up at Stephens Align Technology (ALGN) has added ~1.3% in the pre-market after Stephen upgraded the stock to overweight as a recent analysis of Invisalign App data prompted the firm to conclude a favorable outlook for the company’s revenue growth. Projecting Align to beat Street estimates with its Q2 2021 top-line growth, the analysts led by Chris Cooley have increased the price target to $700.00 from $600.00 per share, implying a premium of ~13.5%. Align could “sustain the favorable top-line growth momentum throughout CY21 as reflected by our above consensus estimates,” Cooley and the team wrote. Align is set to release Q2 2021 results on July 28. Meanwhile, Stephens reiterates the overweight investment rating on Align’s rival, SmileDirectClub (SDC) as they estimate the DIY align manufacturer to sustain a 20 – 30% of organic revenue annual revenue growth with an expansion of adjusted EBITDA margins.

For further details see:

Align upgraded at Stephens, Novan surges on Cantor’s bullish call – in today's analyst action
Stock Information

Company Name: Apellis Pharmaceuticals Inc.
Stock Symbol: APLS
Market: NASDAQ
Website: apellis.com

Menu

APLS APLS Quote APLS Short APLS News APLS Articles APLS Message Board
Get APLS Alerts

News, Short Squeeze, Breakout and More Instantly...